In this study, an analysis of changes in gene expression of ADORA2A, MTA1, PTGDS, HNMT, NSF, and PTGS2 at the mRNA level was performed in the peripheral blood from treated and untreated patients with early stages of PD. This evidence concerns the gene ADORA2A and Parkinson disease.